These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions. Sirinathsinghji DJ; Heavens RP; McBride CS Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784 [TBL] [Abstract][Full Text] [Related]
25. Partial protection from the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by Pro-Leu-Gly-NH2(PLG; MIF-1). Sheng JG; Xu DL; Yu HZ; Xu XR; Tang QM Life Sci; 1987 May; 40(20):2007-10. PubMed ID: 2437428 [TBL] [Abstract][Full Text] [Related]
26. Studies on the acute and long-term changes in dopamine and noradrenaline metabolism in mouse brain following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Pileblad E; Carlsson A Pharmacol Toxicol; 1988 Apr; 62(4):213-22. PubMed ID: 3260379 [TBL] [Abstract][Full Text] [Related]
27. Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice. Vaglini F; Fascetti F; Tedeschi D; Cavalletti M; Fornai F; Corsini GU Neurodegeneration; 1996 Jun; 5(2):129-36. PubMed ID: 8819133 [TBL] [Abstract][Full Text] [Related]
28. Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP). Martinovits G; Melamed E; Cohen O; Rosenthal J; Uzzan A Neurosci Lett; 1986 Aug; 69(2):192-7. PubMed ID: 3489911 [TBL] [Abstract][Full Text] [Related]
29. [The effect of prolyl-leucyl-glycine (MIF-1) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine levels of the striatum]. Sheng JG Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Aug; 22(4):213-5, 253. PubMed ID: 2575971 [TBL] [Abstract][Full Text] [Related]
30. Reversible serotoninergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse striatum studied by neurochemical and immunohistochemical approaches. Hara K; Tohyama I; Kimura H; Fukuda H; Nakamura S; Kameyama M Brain Res; 1987 May; 410(2):371-4. PubMed ID: 3297254 [TBL] [Abstract][Full Text] [Related]
32. Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice. Kitamura Y; Itano Y; Kubo T; Nomura Y J Neuroimmunol; 1994 Mar; 50(2):221-4. PubMed ID: 7509816 [TBL] [Abstract][Full Text] [Related]
33. Diphenylhydantoin and phenobarbital suppress the dopaminergic neurotoxicity of MPTP in mice. Melamed E; Martinovits G; Pikarsky E; Rosenthal J; Uzzan A Eur J Pharmacol; 1986 Sep; 128(3):255-7. PubMed ID: 3491762 [TBL] [Abstract][Full Text] [Related]
34. MPTP toxicity in relation to age, dopamine uptake and MAO-B activity in two rodent species. Jossan SS; Sakurai E; Oreland L Pharmacol Toxicol; 1989 Mar; 64(3):314-8. PubMed ID: 2786198 [TBL] [Abstract][Full Text] [Related]
35. Mesolimbic dopaminergic neurons are not spared by MPTP neurotoxicity in mice. Melamed E; Rosenthal J; Globus M; Cohen O; Frucht Y; Uzzan A Eur J Pharmacol; 1985 Aug; 114(1):97-100. PubMed ID: 3876229 [TBL] [Abstract][Full Text] [Related]
36. Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice. Cosi C; Colpaert F; Koek W; Degryse A; Marien M Brain Res; 1996 Aug; 729(2):264-9. PubMed ID: 8876997 [TBL] [Abstract][Full Text] [Related]
37. Oral versus parenteral efficacy of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): differential effects on depletion of heart norepinephrine and of striatal dopamine in mice. Fuller RW; Hemrick-Luecke SK Biochem Pharmacol; 1987 Mar; 36(6):789-92. PubMed ID: 3494450 [No Abstract] [Full Text] [Related]
38. Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP. Kindt MV; Youngster SK; Sonsalla PK; Duvoisin RC; Heikkila RE Eur J Pharmacol; 1988 Feb; 146(2-3):313-8. PubMed ID: 3131149 [TBL] [Abstract][Full Text] [Related]
39. Kinetics of [3H]MPP+ uptake in dopaminergic neurons of mouse: regional effects of MPTP neurotoxicity. Sershen H; Mason MF; Debler EA; Lajtha A Eur J Pharmacol; 1986 Jul; 126(3):337-9. PubMed ID: 3489627 [TBL] [Abstract][Full Text] [Related]
40. Depletion of striatal dopamine by the N-oxide of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Lau YS; Fung YK; Trobough KL; Cashman JR; Wilson JA Neurotoxicology; 1991; 12(2):189-99. PubMed ID: 1956580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]